|
1
|
Zhao YY, Xu YS and Wu Q: Research progress
on tumor hyperthermia. Chin J Radiat Oncol. 30:862–866. 2021.
|
|
2
|
Yi GY, Kim MJ, Kim HI, Park J and Baek SH:
Hyperthermia treatment as a promising anti-cancer strategy:
Therapeutic targets, perspective mechanisms and synergistic
combinations in experimental approaches. Antioxidants (Basel).
11(625)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Qi BN, Wang XP and Wang XN: The effect and
mechanism of hyperthermia on immune cells. Modern Oncol.
26:2635–2639. 2018.
|
|
4
|
Basile A, Biziato D, Sherbet GV, Comi P
and Cajone F: Hyperthermia inhibits cell proliferation and induces
apoptosis: Relative signaling status of P53, S100A4, and Notch in
heat sensitive and resistant cell lines. J Cell Biochem.
103:212–220. 2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yonezawa M, Otsuka T, Matsui N, Tsuji H,
Kato KH, Moriyama A and Kato T: Hyperthermia induces apoptosis in
malignant fibrous histiocytoma cells in vitro. Int J Cancer.
66:347–351. 1996.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kaczmarek A, Vandenabeele P and Krysko DV:
Necroptosis: The release of damage-associated molecular patterns
and its physiological relevance. Immunity. 38:209–223.
2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Huang Y, Du S, Liu J, Huang W, Liu W,
Zhang M, Li N, Wang R, Wu J, Chen W, et al: Diagnosis and prognosis
of breast cancer by high-performance serum metabolic fingerprints.
Proc Natl Acad Sci USA. 119(e2122245119)2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yin X, Yang J, Zhang M, Wang X, Xu W,
Price CH, Huang L, Liu W, Su H, Wang W, et al: Serum metabolic
fingerprints on bowl-shaped submicroreactor chip for chemotherapy
monitoring. ACS Nano. 16:2852–2865. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li YQ, Yang M and Li XT: Biochemical
processes of ferroptosis and its roles in tumors. Chin J Bioche
Mole Biol. 34:838–843. 2018.
|
|
11
|
Liu J and Liu WT: Research progress of
ferroptosis in digestive system tumors. J Clin Exp Pathol.
38:331–333. 2022.
|
|
12
|
Zeng L, Liao Q, Zhao Q, Jiang S, Yang X,
Tang H, He Q, Yang X, Fang S, He J, et al: Raltitrexed as a
synergistic hyperthermia chemotherapy drug screened in
patient-derived colorectal cancer organoids. Cancer Biol Med.
18:750–762. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev MoI Cell
Biol. 15:178–196. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Chen X and Li HL: Research progress in the
mechanism of epithelial mesenchymal transformation of
hepatocellular carcinoma cells. World Latest Med Information.
22:40–44. 2022.
|
|
16
|
Li D: Effect of intensity-modulated
radiotherapy combined with local hyperthermia on mortalin
expression and its relationship with cell proliferation and EMT in
advanced liver cancer lesions. J Hainan Med Univ. 24:1842–1845.
2018.
|
|
17
|
Yang CX, Wei YH and Wei HF:
Dihydroartemisinin inhibits growth and invasion of hepatoma cells
by inhibiting expression of HMGB2 and reversing process of EMT.
Chin J Immunol. 38:557–562. 2022.
|
|
18
|
Jia XB and Li Q: Research advances on
deubiquitinating enzymes involved in the development of
hepatocellular carcinoma. Chin J Clin Oncol. 47:260–264. 2020.
|
|
19
|
Vaupel P, Schmidberger H and Mayer A: The
Warburg effect: Essential part of metabolic reprogramming and
central contributor to cancer progression. Int J Radiat Biol.
95:912–919. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ling S, Shan Q, Zhan Q, Ye Q, Liu P, Xu S,
He X, Ma J, Xiang J, Jiang G, et al: USP22 promotes hypoxia-induced
hepatocellular carcinoma stemness by a HIF1α/USP22 positive
feedback loop upon TP53 inactivation. Gut. 69:1322–1334.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang FL and Hu J: Research progress on
regulatorymechanism of ubiquitin modification on Warburg effect in
malignant tumors. Cancer Res Prev Treat. 49:616–622. 2022.
|
|
22
|
Lei LM and Xu XL: Effect of intraoperative
peritoneal washes on proliferation of gastric cancer cells in
patients with stomach cancer. Oncol Progress. 18:1634–1636.
2020.
|
|
23
|
Chen J, Wang S and Xu H: Curative effect
of radical gastrectomy combined with peritoneal lavage with thermal
hypoosmotic solution in treatment of gastric cancer. Zhonghua Yi
Xue Za Zhi. 81:730–732. 2001.PubMed/NCBI(In Chinese).
|
|
24
|
Peritoneal Tumor Committee of China Anti
cancer association, Tumor Hyperthermia Committee of Guangdong Anti
cancer association. Expert consensus on clinical application of
intraperitoneal hyperthermic perfusion chemotherapy technology in
China (version 2019). Chin Med J. 100:89–96. 2020.
|
|
25
|
Lu Y, Rivera-Rodriguez A, Tay ZW, Hensley
D, Fung KLB, Colson C, Saayujya C, Huynh Q, Kabuli L, Fellows B, et
al: Combining magnetic particle imaging and magnetic fluid
hyperthermia for localized and image-guided treatment. Int J
Hyperthermia. 37:141–154. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ding SW, Wu CW, Yu XG, Li H, Yu L, Zhang
YX, Yang RP and Zhang W: Magnetic hydrogel with long in situ
retention time for self-regulating temperature hyperthermia. Int J
Hyperthermia. 38:13–21. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bottauscio O, Rubia-Rodríguez I, Arduino
A, Zilberti L, Chiampi M and Ortega D: Heating of metallic biliary
stents during magnetic hyperthermia of patients with pancreatic
ductal adenocarcinoma: An in silico study. Int J Hyperthermia.
39:1222–1232. 2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Shao N and Chen X: Research progress of
superparamagnetic Fe3O4 nanoparticles in the treatment of malignant
tumors. Oncol Progress. 20:1096–1098. 2022.
|
|
29
|
Kim H, Lee D, Kim J, Kim TI and Kim WJ:
Photothermally triggered cytosolic drug delivery via endosome
disruption using a functionalized reduced graphene oxide. ACS Nano.
7:6735–6746. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yang K, Zhang S, Zhang G, Sun X, Lee ST
and Liu Z: Graphene in mice: Ultrahigh in vivo tumor uptake and
efficient photothermal therapy. Nano Lett. 10:3318–3323.
2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Padhani AR and Ollivier L: The RECIST
criteria: Implications for diagnostic radiologists. Br J Radiol.
74:983–986. 2001.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li HM, Jing XX and Liu YS: Effect of
magnetic lipid microbubble-based gene vectors on human HepG2 cell
growth. Chin J Mod Med. 29:16–20. 2019.
|
|
33
|
Enomoto A, Fukasawa T, Terunuma H,
Nakagawa K, Yoshizaki A, Sato S and Miyagawa K: Decrease in MAP3Ks
expression enhances the cell death caused by hyperthermia. Int J
Hyperthermia. 39:200–208. 2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhang N, Zhu H, Dong YH and Wang L:
Establishment of an insufficient radiofrequency ablation orthotopic
nude mouse model of hepatocellular carcinoma to study the
invasiveness and metastatic potential of residual cancer. Oncol
Lett. 18:2548–2553. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Luo X, Ding G, Zheng X, Jin J, Liu Y,
Zhang N, Wang J and Wang A: Improved mouse model of orthotopic
transplantation for hepatocellular carcinoma. Chin J Comp Med.
31:16–22. 2021.
|
|
36
|
Xu J and Li X: Establishment of animal
model of liver cancer. J Clin Hepatol. 8:116–118. 2005.
|
|
37
|
Gao CQ, Zhou XY and Liu JL: Research
progress in mouse treatment model of liver cancer. Chin J
Pathophysiol. 38:1686–1693. 2022.
|
|
38
|
Han PS, Yang L and Cui T: Establishment of
the patient derived liver cancer xenograft model. Chin J Hepatobil
Surg. 28:295–298. 2022.
|
|
39
|
Aboulkheyr Es H, Montazeri L, Aref AR,
Vosough M and Baharvand H: Personalized cancer medicine: An
organoid approach. Trends Biotechnol. 36:358–371. 2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kondo J and Inoue M: Application of cancer
organoid model for drug screening and personalized therapy. Cells.
8(470)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Saltsman JA, Hammond WJ, Narayan NJC,
Requena D, Gehart H, Lalazar G, LaQuaglia MP, Clevers H and Simon
S: A human organoid model of aggressive hepatoblastoma for disease
modeling and drug testing. Cancers (Basel). 12(2668)2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Liu Q, Zhang Z, Liu Y, Cui Z, Zhang T, Li
Z and Ma W: Cancer cells growing on perfused 3D collagen model
produced higher reactive oxygen species level and were more
resistant to cisplatin compared to the 2D model. J Appl Biomater
Funct Mater. 16:144–150. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Mittal R, Woo FW, Castro CS, Cohen MA,
Karanxha J, Mittal J, Chhibber T and Jhaveri VM: Organ-on-chip
models: Implications in drug discovery and clinical applications. J
Cell Physiol. 234:8352–8380. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Lin YZ, Wang JL, Ren HZ, et al: Research
progress on organoids models of liver diseases. J
Hepatopancreatobiliary Surg. 33:380–385. 2021.
|
|
45
|
Liao YL, Liu ZY and Wang H: Research
progress on cultivation and application of liver cancer organoid. J
Med Postgra. 35:664–667. 2022.
|
|
46
|
Zhao B: Application prospects of organoids
in organ transplantation. Organ Transpl. 13:169–175. 2022.
|
|
47
|
Sampaziotis F, Justin AW, Tysoe OC, Sawiak
S, Godfrey EM, Upponi SS, Gieseck RL III, de Brito MC, Berntsen NL,
Gómez-Vázquez MJ, et al: Reconstruction of the mouse extrahepatic
biliary tree using primary human extrahepatic cholangiocyte
organoids. Nat Med. 23:954–963. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
48
|
Sampaziotis F, Muraro D, Tysoe OC, Sawiak
S, Beach TE, Godfrey EM, Upponi SS, Brevini T, Wesley BT,
Garcia-Bernardo J, et al: Cholangiocyte organoids can repair bile
ducts after transplantation in the human liver. Science.
371:839–846. 2021.PubMed/NCBI View Article : Google Scholar
|
